Gandhi Special Tubes: No Tailwinds, No Headwinds Either

"Examining the Risks and Rewards of Investing in the Stock of a Niche Manufacturing Company" Firstly, for the benefit of the uninitiated, a brief introduction to the stock: Gandhi Special Tubes principally manufactures a niche product – small-diameter seamless steel tubes that are supplied to the original equipment manufacturers (OEMs) in the automotive, farm equipment, … Continue reading Gandhi Special Tubes: No Tailwinds, No Headwinds Either →

Star Cement: Is it Worth Investing Now?

Scrutinising Star Cement's Recent Outstanding Performance, Current Valuation, and Investment Prospects The stock of Star Cement gained 10.54 per cent on 22 Mar. 2024 – and closed the day at ₹232 per share – making a new all-time high. The stock now trades at ₹230.60 per share. One-and-a-half years ago, in Sep. 2022, it was … Continue reading Star Cement: Is it Worth Investing Now? →

L G Balakrishnan, Oriental Carbon, Associated Alcohols

This post discusses the investment prospects of L G Balakrishnan & Bros., Oriental Carbon & Chemicals, and Associated Alcohols & Breweries. Convergence The Past One-year Performance of L G Balakrishnan & Bros. illustrates the Importance of Margin of Safety in Stock Investing In April 2023, when we previously discussed it, we were bullish on the … Continue reading L G Balakrishnan, Oriental Carbon, Associated Alcohols →

Stock Musings – Lincoln Pharma, Dynemic Products, Pakka

LINCOLN PHARMA The stock of Lincoln Pharma is up 90 percent in the last year, a commendable feat considering its low earnings growth, mediocre working capital management, and sluggish capital allocation. However, it is not a poor-quality stock. The stock has good fundamentals, such as a debt-free balance sheet and a high and stable gross … Continue reading Stock Musings – Lincoln Pharma, Dynemic Products, Pakka →

Analysis: Q3FY24 Results – II

This post discusses the financial performance of Meghmani Organics, RACL Geartech, and Kovai Medical Center & Hospital for the quarter ended 31 Dec. 2023 and their investment prospects considering these results. Meghmani Organics Meghmani Organics (MOL) reported its Q3FY24 (quarter ended 31 Dec. 2023) results on Jan. 30, 2024. This quarter's financial performance is a … Continue reading Analysis: Q3FY24 Results – II →

Analysis: Q3FY24 Results – I

This post discusses the financial performance of three stocks – Control Print, SRG Housing, and CSB Bank - for the quarter ended 31 Dec. 2023 and our perspective on the respective stocks’ investment prospects considering these results. Control Print Control Print reported its Q3FY24 results on Jan. 22, 2024. Sales and operating profit were up … Continue reading Analysis: Q3FY24 Results – I →

Disparity in Markets

The Disparity between Stock and Money Markets: A Cause for Concern This week was an eventful one. On Tuesday, the IMF in its Jan. 2024 World Economic Outlook (WEO) update, revised upward the world economic output growth to 3.1 percent – 20 basis points higher than projected in its Oct. 2023 outlook. India’s GDP growth … Continue reading Disparity in Markets →

RACL Geartech’s Dream Run in the Stock Market

Evaluating the Investment Potential of RACL Geartech RACL Geartech would be one of the best investment decisions I have ever made, but one of my worst investment decisions too. I first purchased the stock at ₹67 per share in September 2018, which I consider one of my best investment decisions. But almost a year later, … Continue reading RACL Geartech’s Dream Run in the Stock Market →

A Quality Stock, But at a Premium Valuation

Control Print’s Recent Performance Analysis & Investment Stance Update Control Print has reported better earnings growth and profitability for the past two years. Its stock price performance over the past two years reflects this improved profitability. The stock has gained 17 percent in 2022 and 150 percent in 2023. We first discussed ‘Control Print’ in … Continue reading A Quality Stock, But at a Premium Valuation →

Meghmani Organics: A Disappointing Year

Meghmani Organics' disappointing performance; challenges faced by the chemical industry; and positive initiatives for future growth. 8 Dec. 2023 Recap The stock performance of Meghmani Organics has been disappointing for investors in the past year. It experienced a loss of 32% in value, dropping from ₹111 to ₹75 per share. Over the last twelve months, … Continue reading Meghmani Organics: A Disappointing Year →